Signals, Powered By EquityPandit
On Tuesday, Zydus Cadila has said that it has got the final approval from the US health regulator for marketing Pindolol tablets that are used in treating hypertension.
Zydus Cadila has said in a BSE filing that the company has received approval from the US Food and Drug Administration (USFDA) to market the drug in the strengths of 5 mg and 10 mg.
The company has said that it is going to manufacture the drug at the group’s manufacturing facility at the Pharma SEZ in Ahmedabad.
